PAX1 and cervical cancer: Additionally, 15 individual studies showed that single PAX1 methylation allowed the accurate differential diagnosis of cervical cancer/HSIL patients from normal individuals with a sensitivity of 0.80 and a specificity of 0.89 (Kong et al., 2015).